LocalizedmHealthapproach to boostingCOVID-19testing and vaccineliteracy,access, and uptakeamongwomen with criminallegalsysteminvolvement
Project Number1U01MD017415-01
Former Number1U01MH129886-01
Contact PI/Project LeaderRAMASWAMY, MEGHA Other PIs
Awardee OrganizationUNIVERSITY OF KANSAS MEDICAL CENTER
Description
Abstract Text
ABSTRACT
People with criminallegalsysteminvolvement (CLSI) have experienced five times as many COVID-19
infections and have three times the risk of death compared to general population in the U.S. Heavily impacted
by COVID-19 and squarely within NIH health disparities populations, people with CLSI are often poor and
disproportionately from racial and ethnic minority groups. Despite the increased risk of COVID-19, we expect
that only one-half of people with CLSI will get vaccinated. Ongoing COVID-19testing in communities and among
groups that are not vaccinated will be key to containing the pandemic. The messaging that COVID-19testing
will still be important may not be getting through to people who are at risk – a critical driver of disparities.
Our team has a unique opportunity to boost testingliteracy,access, and uptake using mobile health
(mHealth) technologies (text and Web) to reach women with CLSI in community settings who are part of the
existing Tri-City Cohort drawn from geographically and socio-politically diverse cities: Birmingham, AL, Kansas
City, MO/KS, and Oakland, CA. This application is highly responsive to the RADx-UP Phase II call for research
that tests interventions to reduce COVID-19 disparities among underserved populations. Our team is positioned
to embed the proposed study into an existing Web-based women’s health literacy intervention platform
(www.shewomen.org, 2R01CA181047) for women leaving jail. We are also able to immediately push the
mHealthCOVID-19testing literacy intervention to 508 women we have already recruited to a three-city cervical
health study of women with CLSI (R01CA226838), and to promptly make this scalable intervention widely
available to people with CLSI.
We will engage the women as stakeholders to study regional and individual differences in COVID-19testing
and vaccineliteracy,access, and uptake. We will use findings to rapidly develop an mHealth intervention focused
on COVID-19literacy, and then push the intervention to CLSI women in the three cities to boost COVID-19literacy,testing, access, and uptake, and vaccination. Findings will be used to develop dissemination strategies
with stakeholders to push the mHealth intervention to the two million women and 11 million men who interface
with the criminallegalsystem annually in the U.S.
Public Health Relevance Statement
RELEVANCE TO PUBLIC HEALTH
The primary impact of this study is it will intervene on COVID-19 health disparities among an extremely
vulnerable and overlooked population – women with criminallegalsysteminvolvement. The intersectional nature
of mass incarceration, racism, and COVID-19 have already created profound disparities for an already vulnerable
and often overlooked population of women. Once we have developed an easy to use mHealth intervention to
boost COVID-19testing and vaccineliteracy,access, and uptake, we will have an open source set of materials
and technological platform available to the community of people working directly with people leaving the criminallegalsystem – a group of two million women who leave jails annually and another 11 million men.
NIH Spending Category
No NIH Spending Category available.
Project Terms
AddressAttitudeBeliefCOVID-19COVID-19 disparityCOVID-19 health disparityCOVID-19 impactCOVID-19 riskCOVID-19 testCOVID-19testingCOVID-19vaccineCar PhoneCellular PhoneCervicalCitiesCommunitiesDiseaseEvaluationFutureGeneral PopulationGeographic LocationsGeographyGoalsGoldHealthHealth TechnologyImprisonmentIndividual DifferencesInfrastructureInternetInterventionJailKansasLegalsystemMotivationNatureOnline SystemsPersonsPhasePoliticsPopulationPositioning AttributePublic HealthRADx Underserved PopulationsRecommendationResearchResearch PersonnelRiskSARS-CoV-2 infectionSamplingTestingTextTimeUnderserved PopulationUnited States National Institutes of HealthVaccinatedVaccinationVaccinesWomanWomen's GroupWomen's HealthWorkcohortcommunity settingdesigndifferences in accessdissemination strategyethnic minority populationexperiencehealth disparity populationshealth literacyhigh rewardinnovationliteracymHealthmarginalized populationmenmobile computingmortality riskopen sourcepandemic diseasepilot testpost-COVID-19racial minorityracismrecruitregional differencerisk perceptionsecondary outcometesting accessunvaccinateduptakevaccine access
National Institute on Minority Health and Health Disparities
CFDA Code
310
DUNS Number
016060860
UEI
YXJGGNC5J269
Project Start Date
01-January-2022
Project End Date
30-November-2023
Budget Start Date
01-January-2022
Budget End Date
30-November-2022
Project Funding Information for 2022
Total Funding
$1,262,938
Direct Costs
$1,021,421
Indirect Costs
$241,517
Year
Funding IC
FY Total Cost by IC
2022
NIH Office of the Director
$1,262,938
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 1U01MD017415-01
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 1U01MD017415-01
Patents
No Patents information available for 1U01MD017415-01
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 1U01MD017415-01
Clinical Studies
No Clinical Studies information available for 1U01MD017415-01
News and More
Related News Releases
No news release information available for 1U01MD017415-01
History
No Historical information available for 1U01MD017415-01
Similar Projects
No Similar Projects information available for 1U01MD017415-01